Opus Genetics, Inc. (ticker: IRD) is a clinical-stage biotechnology company. Based on the limited text provided from this 10-K filing, the company operates in the genetics/ophthalmology space. The filing does not provide sufficient detail in the extracted section to fully describe specific products or services beyond the company name and general SEC filing structure.
Q2 FY2026 — expected 2026-09-18
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-12 | 2025-12-31 | 0001140361-26-009247 | EDGAR | 100K words |
| 2025-03-31 | 2024-12-31 | 0001140361-25-011410 | EDGAR | — |
| 2024-03-08 | 2023-12-31 | 0001140361-24-012399 | EDGAR | — |
| 2023-03-30 | 2022-12-31 | 0001140361-23-014868 | EDGAR | — |
| 2022-03-24 | 2021-12-31 | 0001140361-22-011015 | EDGAR | — |
| 2021-03-11 | 2020-12-31 | 0001140361-21-008099 | EDGAR | — |
| 2020-02-21 | 2019-12-31 | 0001140361-20-003785 | EDGAR | — |
| 2019-03-07 | 2018-12-31 | 0001140361-19-004539 | EDGAR | — |
| 2018-03-09 | 2017-12-31 | 0001140361-18-012817 | EDGAR | — |
| 2017-02-24 | 2016-12-31 | 0001140361-17-009132 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-06 | 2026-06-30 | 0001628280-26-054381 | EDGAR | — |
| 2025-11-12 | 2025-09-30 | 0001140361-25-041547 | EDGAR | 34K words |
| 2025-08-13 | 2025-06-30 | 0001140361-25-030836 | EDGAR | — |
| 2025-05-15 | 2025-03-31 | 0001140361-25-019266 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0001140361-24-046045 | EDGAR | — |
| 2024-08-13 | 2024-06-30 | 0001140361-24-037068 | EDGAR | — |
| 2024-05-10 | 2024-03-31 | 0001140361-24-025481 | EDGAR | — |
| 2023-11-13 | 2023-09-30 | 0001140361-23-052749 | EDGAR | — |
| 2023-08-11 | 2023-06-30 | 0001140361-23-039196 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0001140361-23-024504 | EDGAR | — |
| 2022-11-04 | 2022-09-30 | 0001140361-22-040029 | EDGAR | — |
| 2022-08-12 | 2022-06-30 | 0001140361-22-029461 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-06 | 0001628280-26-053824 | EDGAR | — |
| 2026-03-10 | 0001140361-26-008621 | EDGAR | 3K words |
| 2026-02-19 | 0001140361-26-006176 | EDGAR | — |
| 2026-01-12 | 0001140361-26-000913 | EDGAR | — |
| 2026-01-08 | 0001140361-26-000615 | EDGAR | — |
| 2025-12-19 | 0001140361-25-046187 | EDGAR | — |
| 2025-11-12 | 0001140361-25-041544 | EDGAR | — |
| 2025-11-06 | 0001140361-25-040796 | EDGAR | — |
| 2025-11-06 | 0001140361-25-040675 | EDGAR | — |
| 2025-09-30 | 0001140361-25-036637 | EDGAR | — |
353 total filings indexed. 321 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001228627 |
| Ticker | IRD |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.opusgtx.com |
| Listed | 2020-11-06 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/IRD (~200 tokens, structured JSON with cryptographic provenance)